Navigation Links
Clinical Trial Establishes Catheter-Based Aortic Valve Replacement as New Standard of Care for Patients Who Cannot Undergo Surgery
Date:9/22/2010

WASHINGTON, Sept. 22 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Transcatheter aortic-valve implantation (TAVI) is a new procedure in which a bioprosthetic valve is inserted through a catheter and implanted within the diseased native aortic valve. The Placement of AoRtic TraNscathetER valves (PARTNER) trial is a multicenter, randomized clinical trial comparing TAVI with standard therapy in high-risk patients with severe aortic stenosis. The co-principal investigators are Martin B. Leon, M.D., and Craig R. Smith, M.D., at NewYork-Presbyterian Hospital/Columbia University Medical Center. The data published today reflect a prespecified cohort of patients who were considered to be unsuitable candidates for surgery.

The primary end point was the rate of death from any cause over the duration of the study. A total of 358 patients with aortic stenosis who were considered to be unsuitable candidates for surgery underwent randomization at 21 centers, including 17 in the United States. Patients randomized for standard therapy received a combination of watchful waiting, medications, and balloon aortic valvuloplasty, which can provide transient clinical benefit but does not alter long-term outcomes.

At one year, patients who underwent TAVI showed a 45 percent reduction in the rate of death from any cause compared with patients who received standard therapy (30.7 percent vs. 50.7 percent) and a 54 percent reduction in the combined end point of death from any cause or repeat hospitalization (42.5 percent with TAVI vs. 71.6 percent with
'/>"/>

SOURCE NewYork-Presbyterian Hospital/Columbia University Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  CVS Caremark (NYSE: CVS ... clinical affiliation with MedStar Health, a leading health care ... and the Washington, DC , ... care services for patients. Through this clinical affiliation, MedStar ... support, medication counseling, chronic disease monitoring and wellness programs ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
(Date:8/27/2014)... Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... H. Mackaness is scheduled to make an investor presentation ... 2:55 p.m. Eastern Time on Wednesday, September 3, in New ... the investor presentation will be available in the Investors section ... About IRIDEX IRIDEX Corporation was founded in ...
Breaking Medicine Technology:CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical ... President and Chief Executive Officer (CEO).  Thomas Beck, M.D., ... resume his role as Chief Medical Officer of the ... cream, is concluding Phase 3 clinical trials to support ...
... N.C., Nov. 17, 2010 Patients with Chronic Obstructive ... disease as both a burden they must deal with ... recent in-home research conducted by GlaxoSmithKline.  Patients participating in ... combination of factors including loss of energy, loss of ...
Cached Medicine Technology:Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 2Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer 3COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 2COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 3
(Date:8/27/2014)... 27, 2014 China’s regulatory framework ... of dramatic changes. The country’s new leaders have ... of medical equipment are far from being alongside ... past 30 years. Chinese state council issued the ... Medical Devices” to try to completely change such ...
(Date:8/27/2014)... Toronto, Ontario (PRWEB) August 27, 2014 When ... getting a call from his mother; one that he credits ... ever received. His mom had news that she could set ... camp supporting people with disabilities. Jagger took that job, and ... the disabled. Throughout these past two decades, he also worked ...
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- A new study ... effective treatment for seniors with sleep apnea. CPAP ... sleep apnea, a condition in which the airway relaxes ... sleep that leads to daytime drowsiness. ... of air through a patient,s nose via a mask ...
(Date:8/27/2014)... parents shapes many aspects of our lives. But in ... is set during development, but can be altered by ... of our parents and grandparents. , The epigenome consists ... that determine whether genes are expressed or silenced. , ... health, but also that it may be possible to ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president ... the NPSF Lucian Leape Institute, is among the 100 Most ... of Modern Healthcare magazine. Also on the list are NPSF ... MBA; NPSF Lucian Leape Institute members Carolyn Clancy, MD; ... member of both the Institute and the NPSF Board of ...
Breaking Medicine News(10 mins):Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 2Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3
... BMR, TORONTO, March 12 /PRNewswire-FirstCall/ - ... in the development and,commercialization of cancer therapies, ... year operational and financial results., Operational ... 31, 2007, the Company achieved the,following steps ...
... INDIANAPOLIS and LONDON, March 12 Today Eli,Lilly ... to the World,Health Organization (WHO) for scaling up ... (MDR-TB) programs., The grant covers four activities, ... to developing countries that the Global,Fund to Fight ...
... Rosa and Santa Rosa Memorial, Hospital to ... make Memorial responsive to its workforce ... In the wake of,news about Sonoma County,s healthcare ... already engaged in a multi-year effort,to win an effective ...
... Brazil, March 11 Amilpar,(BOVESPA: AMIL3, Bloomberg: AMIL3 ... in Brazil, announced today its consolidated,results for the ... The Company,s,operational and financial information is presented on ... with Brazilian Corporate Law and the,Accounts Chart of ...
... blood test that would show whether an antidepressant is ... say they,ve discovered a biomarker for depression that could ... a particular antidepressant is making headway against the disease. ... for depression," said study co-author Mark Rasenick, director of ...
... Speaks on Behalf of People with ... Diabetes During Congressional Briefing, WASHINGTON, March 11 ... of Congress to support,a bill that will develop a national ... was joined today at a briefing on Capitol,Hill by a ...
Cached Medicine News:Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 2Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 3Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 4Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 5Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 6Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 7Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 8Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 9Health News:Bradmer announces 2007 fourth quarter and fiscal year operational and financial results 10Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 2Health News:Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion 3Health News:Santa Rosa Healthcare Workers Seek Accountability From Catholic Hospital System 2Health News:Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007 2Health News:Scientists Spot Biochemical Sign of Depression 2Health News:Scientists Spot Biochemical Sign of Depression 3Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 2Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 3
... Medical Delta valve is designed to ... and maintain intraventricular pressure (IVP) within ... patient position. The normally closed Delta ... positive ventricular pressure. Working with the ...
... is an adjustable flow control valve in ... can be changed non-invasively by the caregiver. ... cerebrospinal fluid (CSF) and maintain intraventricular pressure ... of patient position. The normally closed Delta ...
...
... try Cadwell paired disc electrodes. They combine ... contacts are 10 mm (0.4 in) in ... steel with a locator pin on the ... and available in twisted pairs. Shielded paired ...
Medicine Products: